We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 9734S
GlaxoSmithKline PLC
14 July 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms E Walmsley ==== ====================================== ================================================= b) Position/status Chief Executive Officer ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 2,005.711 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr R Connor ==== ====================================== ================================================= b) Position/status President, Global Vaccines ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 1,454.800 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms D Conrad ==== ====================================== ================================================= b) Position/status SVP, Human Resources ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 7.839 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ===== ============================================================================================== a) Name Mr J Ford ===== ======================================== ==================================================== b) Position/status SVP & General Counsel ===== ======================================== ====================================================
c) Initial notification/ Initial notification amendment ===== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ===== ============================================================================================== a) Name GlaxoSmithKline plc ===== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ===== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ===== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ===== ======================================== ==================================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 9 July 2020. ===== ======================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ===== ======================================== ====================== ========================= $40.0723 72.213 ====================== ========================= d) Aggregated information N/A (single transaction) ===== Aggregated volume Price ========================================= ========================================================= e) Date of the transaction 2020-07-10 ===== ======================================== ==================================================== 4f) Place of the New York Stock Exchange (XNYS) transaction ===== ======================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr J Ford ==== ====================================== ================================================= b) Position/status SVP & General Counsel ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 0.000027 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr N Hirons ==== ====================================== ================================================= b) Position/status SVP, Global Ethics & Compliance ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 727.832 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ===== ========================================================================================= a) Name Ms S Jackson ===== ====================================== ================================================= b) Position/status SVP, Global Communications and CEO Office ===== ====================================== ================================================= c) Initial notification/ Initial notification amendment ===== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ===== ========================================================================================= a) Name GlaxoSmithKline plc ===== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793 ===== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ===== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ===== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ===== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ===== ====================================== ========================= =================== GBP15.7733 190.652 ====================================================================== =================== d) Aggregated information N/A (single transaction) ===== Aggregated volume Price ================================================================== =========================== e) Date of the transaction 2020-07-10 ===== ====================================== ================================================= 4f) Place of the London Stock Exchange (XLON) transaction ===== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr D Jackson ==== ====================================== ====================================================== b) Position/status PCA of Ms S Jackson ( SVP, Global Communications and CEO Office) ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ====================================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP15.7733 90.180 ======================================================================= ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================= e) Date of the transaction 2020-07-10 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr B McNamara ==== ======================================== ==================================================== b) Position/status CEO, GSK Consumer Healthcare ==== ======================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GlaxoSmithKline plc ==== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================== ==================================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 9 July 2020. ==== ======================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ====================== ========================= $40.0723 963.868 ====================== ========================= d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= ======================================================== e) Date of the transaction 2020-07-10 ==== ======================================== ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ===== ========================================================================================= a) Name Mr L Miels ===== ====================================== ================================================= b) Position/status President, Global Pharmaceuticals ===== ====================================== ================================================= c) Initial notification/ Initial notification amendment ===== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ===== ========================================================================================= a) Name GlaxoSmithKline plc ===== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ===== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
===== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ===== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ===== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ===== ====================================== ========================= =================== GBP15.7733 2,508.442 ====================================================================== =================== d) Aggregated information N/A (single transaction) ===== Aggregated volume Price ================================================================== =========================== e) Date of the transaction 2020-07-10 ===== ====================================== ================================================= 4f) Place of the London Stock Exchange (XLON) transaction ===== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr D Redfern ==== ====================================== ================================================= b) Position/status Chief Strategy Officer ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 3,253.864 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr R Simard ==== ====================================== ================================================= b) Position/status President, Pharmaceuticals Supply Chain ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 641.653 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr P Thomson ==== ====================================== ================================================= b) Position/status President, Global Affairs ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020.
==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 383.416 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms K Thomson ==== ====================================== ================================================= b) Position/status PCA of Mr P Thomson (President, Global Affairs) ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 133.156 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms D Waterhouse ==== ====================================== ================================================= b) Position/status Chief Executive Officer of ViiV Healthcare ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 9 July 2020. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP15.7733 256.431 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2020-07-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== =================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLZLFFBDLFBBQ
(END) Dow Jones Newswires
July 14, 2020 08:19 ET (12:19 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions